Hims & Hers Health, Inc. (NYSE:HIMS) Short Interest Update Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) saw a large decline in short interest during the month…
Hims & Hers Health (NYSE:HIMS) Shares Gap Down to $21.56 Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s stock price gapped down prior to trading on Thursday .…
17,400 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Acquired by B. Riley Wealth Advisors Inc. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free…
Hims & Hers Health (NYSE:HIMS) Given New $23.00 Price Target at Jefferies Financial Group Hims & Hers Health (NYSE:HIMS – Free Report) had its target price raised by Jefferies Financial Group from $14.00 to…
HIMS Stock Tumbles: Heres Why Its a Buy Right Now Hims & Hers Health is a high growth, healthcare startup stepping into the GLP-1 space.…
Hims & Hers shares fall on Hunterbrook report that GLP-1 drugs come from shady supplier Sam Koppelman, Hunterbrook Media publisher and co-founder, joins Closing Bell Overtime to talk its report that Hims & Hers GLP-1…
Hims & Hers Stock Drops 12.8% After Short Report Is this a warning or a buy sign for Hims & Hers stock?…
Hims & Hers Health (NYSE:HIMS) Stock Price Down 11.6% Hims & Hers Health (NYSE:HIMS) Trading Down 11.6%…
Hims & Hers Health Stock Is Sliding Thursday: Whats Going On? Hims & Hers Health, Inc (NYSE:HIMS) shares are trading lower Thursday after Hunterbrook issued a short report on the stock.…
Hims & Hers Health Stock Is Sliding Thursday: Whats Going On? - Hims & Hers Health (NYSE:HIMS) Hunterbrook releases a bearish report alleging that Hims & Hers sells knockoff GLP-1 weight loss drugs and relies on a…
Hims & Hers Health (NYSE:HIMS) Shares Gap Down to $21.56 Hims & Hers Health (NYSE:HIMS) Shares Gap Down to $21.56…
Hims & Hers down 6% following report on shady supplier for weight loss drug (NYSE:HIMS) Hims & Hers Health stock declines following controversy over accessibility and supplier of GLP-1 weight loss drugs. Read more here.…
Hims & Hers down 6% following report on shady supplier for weight loss drug Hims & Hers Health (NYSE:HIMS) is down ~6% following a report that is raising eyebrows both on how easy it is to…
Hims & Hers Health (NYSE:HIMS) Shares Up 3.2% Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shot up 3.2% during mid-day trading on Tuesday . The…
Hims & Hers falls after Hunterbrook Media report on GLP-1 drug sales Hunterbrook Media issued a report on Hims Hers this morning and noted that based on its reporting, Hunterbrook Capital…
Hims & Hers Health (NYSE:HIMS) Shares Down 4.2% on Insider Selling Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares fell 4.2% on Wednesday following insider selling activity. The…
Hims & Hers Health (NYSE:HIMS) Shares Down 4.2% After Insider Selling Hims & Hers Health (NYSE:HIMS) Stock Price Down 4.2% on Insider Selling…
Hims & Hers Health, Inc. (NYSE:HIMS) CFO Oluyemi Okupe Sells 11,546 Shares of Stock Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) CFO Oluyemi Okupe sold 11,546 shares of the firm’s stock…